First of Its Kind Investment Competition for Female-Led Cancer-Focused Start-Ups ROCKVILLE, MD – The AIM-HI Accelerator Fund is organizing the first annual Women’s Venture Competition on May 20 in Boston. Applications are being accepted online until April 16 from oncology…
ROCKVILLE, MD – The co-founder and CEO of the AIM-HI Accelerator Fund will chair a panel conversation at an event coinciding with the annual JP Morgan Healthcare Conference. On Sunday, January 12, Sujuan Ba, Ph.D., will lead a morning discussion…
ROCKVILLE, MD – A portfolio start-up company of the AIM-HI Accelerator Fund has been awarded $700,000 from Virginia Catalyst to commercialize its lead cancer drug candidate. Richmond-based InterLeukin Combinatorial Therapies (ILCT) is developing unique engineered therapeutic interleukins (a type of…
By Franklin C. Salisbury, Jr. The National Foundation for Cancer Research funds “high risk|high reward” research with a singular focus on one absolute and immutable goal: research to cure cancer – cures for all types of cancer. Since 1973 with…
